Rocket
Premium
Excel Add-In
International
Tools
Dashboard
Screener
Spinoffs
IPOs
Register
Alerts
Sign In
Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Satsuma Pharmaceuticals, Inc. (STSA)
Create:
Alert
All
|
News
|
Filings
Date Filed
Type
Description
06/08/2023
8-K
Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Fa...
Docs:
"
Fifth Amended and Restated Certificate of Incorporation of the Company
",
"
Amended and Restated Bylaws of the Company
"
05/18/2023
8-K
Other Events, Financial Statements and Exhibits Interactive Data
Docs:
"
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
",
"
Satsuma Pharmaceuticals Announces FDA Acceptance of 505 NDA for STS101, a Novel and Investigational Dihydroergotamine Nasal Powder Product for the Acute Treatment of Migraine
"
04/17/2023
8-K
Quarterly results
03/28/2023
8-K
Quarterly results
12/20/2022
8-K
Quarterly results
11/30/2022
8-K
Quarterly results
11/14/2022
8-K
Quarterly results
11/03/2022
8-K
Quarterly results
11/03/2022
8-K
Quarterly results
10/28/2022
8-K
Quarterly results
09/20/2022
8-K
Other Events, Financial Statements and Exhibits Interactive Data
Docs:
"
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
",
"
Satsuma Pharmaceuticals Announces Positive Results from the Ongoing STS101 ASCEND Phase 3 Open-label, Long-term Safety Trial
"
08/09/2022
8-K
Quarterly results
Docs:
"
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
",
"
Satsuma Pharmaceuticals Reports Second Quarter 2022 Financial Results and Recent Progress in STS101 Development Program
"
06/07/2022
8-K
Quarterly results
05/10/2022
8-K
Quarterly results
03/15/2022
8-K
Quarterly results
Docs:
"
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
",
"
Satsuma Pharmaceuticals Reports 2021 Full Year and Fourth Quarter Financial Results and Business Highlights
"
11/09/2021
8-K
Quarterly results
Docs:
"
Satsuma Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Corporate Update
"
10/12/2021
8-K
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
08/10/2021
8-K
Quarterly results
06/16/2021
8-K
Quarterly results
06/02/2021
8-K
Quarterly results
05/11/2021
8-K
Quarterly results
03/25/2021
8-K
Quarterly results
03/01/2021
8-K
Quarterly results
11/10/2020
8-K
Quarterly results
Docs:
"
Satsuma Pharmaceuticals Provides Business Update and Reports Third Quarter 2020 Financial Results
"
09/10/2020
8-K
Other Events
08/11/2020
8-K
Quarterly results
07/07/2020
8-K
Quarterly results
06/15/2020
8-K
Submission of Matters to a Vote of Security Holders
Docs:
"
FORM 8-K
"
05/12/2020
8-K
Quarterly results
Docs:
"
Satsuma Pharmaceuticals Reports First Quarter 2020 Financial and Business Results
"
03/10/2020
8-K
Quarterly results
Docs:
"
FORM 8-K
",
"
Satsuma Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results and Recent Business Results
"
11/12/2019
8-K
Quarterly results
09/17/2019
8-K
Quarterly results
Rocket Data Systems, Inc. © 2019 |
Contact Us
|
Data Disclaimer
|
Terms of Use
|
Privacy